HBOT Conversations:

Jim Hooker & HBOT for Vets (Part 1)

Mr. Hooker founded Stratford, Wayne & Associates LTD, a Virginia based corporation in 1982 after completing a 20-year career in the U.S. Navy. He is a specialist in government financial management and systems acquisition with extensive experience in contracting, acquisition strategy, pricing strategy, business and source selection processes. Since 2007 Mr. Hooker has been focused on supporting injured combat veteran families returning home.

In early 2010 Mr. Hooker cofounded, and served as the Chief Operating Officer of a foundation which had as its mission to support the successful transition of Wounded In Action (WIA) military families into the civilian community. As a result of his work in support of seriously injured veterans being treated at the Walter Reed National Military Medical Center (WRNMMC) at Bethesda, Maryland, Mr. Hooker has become proficient in understanding and the treatment of Traumatic Brain Injury (TBI) and Post Traumatic Stress Disorder (PTSD).

Mr. Hooker also directed the preparation of a video describing a “Soldiers Combat Experience and Homecoming” with a retired, TBI hyperbaric oxygen therapy (HBOT) recovered, U.S. Army Major. He initiated and executed interactions with a marine corps wounded warrior battalion medical staff, stimulating the prescribed use of HBOT for TBI/PTSD wounded marine families; while identifying, resourcing and supporting several TBI/PTSD injured active duty and veteran personnel through successful HBOT. Mr. Hooker is a known author on several articles published in the North Carolina Medical Journal on TBI and PTSD veteran care in North Carolina, and he authored NC Law 2019-175 authorizing prescribed HBOT for veterans with TBI and PTSD injuries, signed into law by the North Carolina Governor on 26 July, 2019.

Subscribe. Join the discussion. Share the hope.

Watch the Podcast

HBOT News welcomes Jim Hooker, a 83 year old retired Navy Vietnam veteran, who served our country for 20 years. After leaving the military, he spent the next 36 years in Washington D.C., and during that time he got involved with a church ministry that was taking care of injured veterans. One thing lead to another and that ministry paved the way for Jim to become Chief Operating Officer of the Wounded In Action Family Foundation. Their mission was to bring the injured men and women home after they were discharged from the hospitals, because the military doesn’t do a very good job of telling vets how to get home to their families, or preparing the family for what they will soon experience living with an injured veteran of war.

Jim tells the story of his very first case.  It was a triple amputee, young man in the Army, who was married and had five children, Jim’s foundation spent $400,000 over 36 months getting this vet to where they thought was settled and ready to come home. They got him registered in a community college, set up his wife with a job, put his kids in school, and they even set the family up with a home in Maryland. They did everything they could think of to bring him home to the best environment possible, but he never came home.  He never came home because “his head didn’t work”; he had sustained too much brain damage from the blast that took his three limbs. Jim was left extremely frustrated and distraught that the mission ultimately failed — they spent all this time, energy, and money and in the end he never came home.

Soon after, Dr. Paul Harch came across Jim’s television.  It seemed like divine intervention that Dr. Harch was talking about Hyperbaric Oxygen Therapy and how it heals injured brains that have PTSD and TBI. At the time (10 years ago), Jim didn’t even know what Post-Traumatic Stress Disorder (PTSD) and Traumatic Brain Injury (TBI) was. Jim’s wife encouraged him to pay attention to what she was watching on the television, and Jim did.  He called Dr. Harch and asked if he could come to the Harch Institute in New Orleans to learn more about Hyperbaric Oxygen Therapy for veterans. Dr. Harch not only welcomed Jim, they spent about two days together discussing HBOT and brain healing.  In time, Jim was eventually introduced to Major Ben Richards, a patient of Dr. Harch’s.

Ben was an Army veteran who experienced a very severe TBI in combat.  Ben was told that he needs to just get used to this new normal, and was sent on his way to live the rest of his life with a brain injury. Ben became suicidal, but crossed paths with one of Dr. Harch’s past patients who stressed that there is a therapy out there that works to heal brain injuries…. she introduced him to HBOT and Dr. Harch.  Dr. Harch treated Ben pro bono, and Jim also met with Ben at the beginning of his dive sessions. Jim refers to Ben as a man who couldn’t keep his balance to stand, his speech was slurred, and his vision was a mess. Keeping track of his progress, Jim witnessed Ben start to make a beautiful recovery after 40 dives, and then a complete recovery after 80 HBOT sessions.  They told his story to the world and Jim has since been a strong voice recommending HBOT to treat and cure veterans who are battling PTSD and TBI.  Jim, Ben, and Dr. Harch made a video that he recommends everyone watch, called “A Soldier’s Story of Combat and Homecoming”.  Ben continued to do Hyperbaric Oxygen Therapy dives and as of how he’s completed about 120 dives and is absolutely thriving in life.

Jim trusted that Ben’s story was just the start to helping so many other veterans. So he went on a mission to find the proof and to show the proof that this works!  Hyperbaric Oxygen Therapy not only can save the lives of our veterans, but it can free them from the chains of PTSD and TBI.  Jim has relied on his faith to lead him on this journey where he can help as many veterans as possible get the HBOT treatment they deserve.  He says meeting host, Ed di Girolamo, was one stop on his walk of faith, and he’s grateful to have met another veteran and someone so adverse in the world of HBOT who shares the same passion and drive to make a difference.

Over time, Jim met with State Legislators in North Carolina, and congressmen and women who have all listened to him as he lobbied for funding from the state to heal their veterans the way they deserve.  With the help of Dr. Greg Murphy, a doctor within the assembly of North Carolina, Jim has educated countless decision makers on the power of Hyperbaric Oxygen Therapy and has delivered all the proof that the answer to healing our vets is oxygen + pressure.

The law was passed under Senate Bill 442, allocating $150,000 to help veterans get 40 or more Hyperbaric Oxygen Therapy treatments. Things moved quickly after that…. the HBOT for Vets website was born at the hands of a local television personality, Mike Weeks; Melissa Spain at the Community Foundation of Eastern NC was appointed the fiduciary of the funds; and Jim has been handling the incoming requests for HBOT treatment, sending approved vets to Extivita-RTP to complete the 40 Hyperbaric Oxygen Therapy sessions that are paid for with the allocated state funds.

Jim reminds us that for anyone who has suffered a head injury, sometimes it’s hard to see the positive progress they are making because the brain heals so slowly. But he urges North Carolina veterans to try it and stick with it, because better days are bound to be within your reach. He outlines all the symptoms of a brain injury, and urges you to seek out Hyperbaric Oxygen Therapy if you or a loved one has suffered a brain injury.

*This interview is part of a two part series with Jim Hooker, stay tuned next week on 2/17 when we release Part 2

Guest

Robert Beckman

Jim Hooker

Mr. Hooker founded Stratford, Wayne & Associates LTD, a Virginia based corporation in 1982 after completing a 20-year career in the U.S. Navy. He is a specialist in government financial management and systems acquisition with extensive experience in contracting, acquisition strategy, pricing strategy, business and source selection processes.  Since 2007 Mr. Hooker has been focused on supporting injured combat veteran families returning home.

During his last several years in the Navy, Mr. Hooker was assigned to several positions in the Joint (Navy/Air Force) Cruise Missiles Project Office (JCMPO). Initially, Mr. Hooker was the Director of Organization and Management. During this assignment he was responsible for the creation and staffing of the joint program, a 360-person organization composed of both military and civilian personnel. Subsequently, Mr. Hooker was the Director of Resources Management executing JCMPO financial management, budgeting, resources management, and cost analysis responsibilities. In this capacity, he served as the principal advisor to the Director of the JCMPO on all financial matters including preparation and presentation of budget justifications to the Navy, Air Force, DoD and congress. For the two years prior to his departure from the Navy, Mr. Hooker was the Director of Contracts. In this position, Mr. Hooker supervised 46 personnel, including 26 contracting officers. The division awarded approximately two billion dollars worth of contracts annually to over 50 different contractors. During this period, Mr. Hooker authored a number of unique and complex terms and conditions including special incentive arrangements requiring congressional approval. In early 2010 Mr. Hooker cofounded, and served as the Chief Operating Officer of a foundation which had as its mission to support the successful transition of Wounded In Action (WIA) military families into the civilian community. As a result of his work in support of seriously injured veterans being treated at the Walter Reed National Military Medical Center (WRNMMC) at Bethesda, Maryland, Mr. Hooker has become proficient in understanding and the treatment of Traumatic Brain Injury (TBI) and Post Traumatic Stress Disorder (PTSD).

Examples of work accomplished include:  Prepared a detailed strategy and plan to implement accessibility of effective treatment for veterans with Traumatic Brain (TBI) and Post Traumatic Stress Disorder (PTSD) injuries. Directed the preparation of a video describing a “Soldiers Combat Experience and Homecoming” with a retired, TBI hyperbaric oxygen therapy (HBOT) recovered, U.S. Army Major. Initiated and executed interactions with a marine corps wounded warrior battalion medical staff, stimulating the prescribed use of HBOT for TBI/PTSD wounded marine families. Identified, resourced and supported several TBI/PTSD injured active duty and veteran personnel through successful HBOT. Authored several articles published in the North Carolina Medical Journal on TBI and PTSD veteran care in North Carolina. Authored NC Law 2019-175 authorizing prescribed HBOT for veterans with TBI and PTSD injuries, signed into law by the North Carolina Governor on 26 July, 2019. Supported North Carolina budget legislation resulting in the appropriation of funds to treat TBI/PTSD wounded Veterans with HBOT. Assisted in the implementation of the North Carolina HBOT program to treat veteran families with TBI and PTSD injuries. This program was funded by the 2021 and 2022 North Carolina legislatures and over 40 veterans have been treated or are in therapy as a result.

Mr. Hooker received a Bachelor of Science Degree, in Commerce and Finance, from Villanova University and an M.B.A. from the U.S. Naval Post Graduate School, Monterey, California.

Subscribe Now, It’s Free!

[contact-form-7 id="65934" title="Subscribe"]

Recent HBOT News

Clinical Trial – HBOT Late Radiation Tissue Injury

Background: Radiotherapy is a common treatment for many malignancies. Radiation-related
complications developing months or years after radiation treatment are known as late
radiation tissue injury (LRTI) and are estimated to effect 5%-15% of all long-term survivors
who have received radiation.

Hyperbaric oxygen therapy (HBOT) is a well established treatment of LRTI. Most of the studies
evaluating effect of HBOT on LRTI are focused on survival, resolution of tissue damage and
improvement in LENT-SOMA scale. Very few studies have addressed effect of HBOT on pain in
LTRI. Krahn and colleagues were the first to report the analgesic effect of HBOT in 3 cases
of refractory pain in oncological patients with radiation soft tissue injury. Other studies
showed significant improvement in pain intensity in patients with breast cancer and pelvic
malignancies treated with HBOT for LTRI. In patients that had developed radiation- induced
brachial plexopathy, HBOT elicited an increase in warm pain thresholds and a reduction in
lymphoedema. A prospective case study of 16 patients with gynecological cancer found no
changes with respect to pain and depression outcomes. A trial in patients with radiation
induced proctopathy showed that 75% of patients with rectal pain had some improvement,
although none experienced a complete resolution of pain symptoms.

There are several mechanisms by which HBOT may elicit analgesic effects. There is a growing
body of evidence that HBOT’s analgesic effect related to nitric oxide metabolism and
endogenous opioid secretion. Furthermore, the inhibition of tumor necrosis factor alph
(TNF-α), the production of substance P, and the modulation of serotonergic pathways have all
demonstrated a modification in the pain response following HBOT. In animal studies HBOT
decreased allodynia and hyperalgesia in different models of neuropathic and inflammatory
pain. The long lasting antinociceptive effect of HBOT was found to be dose-dependent in
non-injured tissues.

In human studies, HBOT decreased pain and edema and improved function in patients suffering
from the complex regional pain syndrome, and improved pain scores and range of motion in
patients with idiopathic femoral head necrosis. Women suffering from interstitial cystitis
demonstrated a reduction in pelvic pain following weeks and months of HBOT treatment. In
patients suffering from idiopathic trigeminal neuralgia HBOT produced a rapid reduction in
symptoms and these effects were lasting for 6 months following treatment. HBOT was also found
to be an effective treatment for cluster headaches and migraines and alleviated muscle and
bone pains in patients with myofascial syndrome, fibromyalgia, and biphosphonate-related
osteonecrosis of the jaw.

Based on the evidence presented above and HBOT’s known analgesic effect in many conditions,
the investigators designed this study with the objective to evaluate if HBOT reduces pain,
improves depression and impacts on patients quality of life in patients suffering from late
radiation tissue injury.

Study Design: Prospective observational study (n=300). Patients that have had radiation
therapy for malignancy, developed late radiation injury and suffer from chronic pain.

Clinical Trial – HBOT in Fibromyalgia

Fibromyalgia (FM) is a chronic pain condition affecting several millions of Canadians.
Although the etiology and pathophysiology are poorly understood, there is a well-recognized
association between muscular pain in fibromyalgia and muscular hypoperfusion, hypoxia,
abnormal muscle metabolism and oxidative stress. Currently there is no cure for FM.
Pharmacological and non-pharmacological strategies are directed to control symptoms such as
pain, fatigue, non-restorative sleep and depression.

Hyperbaric oxygen therapy (HBOT) is an intermittent inhalation of 100% oxygen in a hyperbaric
chamber at a pressure higher than 1 absolute atmosphere. Physiological effect of HBOT is
based on a dramatic increase in the amount of dissolved oxygen carried by the blood which
enables oxygenation of ischemic areas with compromised circulation. It also activates
oxidant-antioxidant system, stimulates angio- and neurogenesis, modulates inflammatory
response, induces brain neuroplasticity and possesses analgesic effect.

While some interventions offer benefit for some patients, additional treatment alternatives
are needed for patients with FM in whom currently available options are either ineffective or
poorly tolerated. Given its physiological effect, HBOT could be considered as a potential
therapy for treatment of underlying muscular hypoxia, optimizing oxidant- antioxidant system
and controlling FM symptoms. The results from this study could therefore provide new
information supporting the basic science underling the pathophysiology of this disease and
stimulate novel therapies for patients suffering with FM.